BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KQB368 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KQB368\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07542704-2583@assetmemo.bio
DTSTAMP:20261121T005437Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:KQB368: Phase 1 readout est. (NCT07542704)
DESCRIPTION:KQB368\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study 
 to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Partici
 pants With Advanced Solid Malignancies\nEstimated primary completion: Dece
 mber 2029. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/kqb368#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0754270
 4
URL:https://assetmemo.bio/drug/kqb368#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
